Aaron Mendelsohn - 15 Oct 2026 Form 4 Insider Report for Vivani Medical, Inc. (VANI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Oct 2026, 16:46:32 UTC
Prior SEC filing
25 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anthony Baldor, Attorney-in-fact
Filing notes and source

Key filing fact

Aaron Mendelsohn filed Form 4 for Vivani Medical, Inc. (VANI) on 19 Oct 2026.

Key facts

  • This page summarizes Aaron Mendelsohn's Form 4 filing for Vivani Medical, Inc. (VANI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Oct 2026, 16:46.

Change

  • Previous filing in this sequence was filed on 25 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001625195 Primary reporting owner

Mendelsohn Aaron

Relationship
Director
Address
C/O VIVANI MEDICAL, INC., 1350 S. LOOP ROAD, ALAMEDA
Signature
/s/ Anthony Baldor, Attorney-in-fact
Signature date
15 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VANI transaction

Common Stock

Gift

Transaction value
Shares
-20,000
Change %
-11%
Price
$0.000000*
Shares after
168,170
Date
15 Oct 2026
Ownership
Direct
Footnotes
F1
VANI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
898,317
Date
15 Oct 2026
Ownership
See footnote
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Gift of 20,000 shares made to a non-affiliated entity on 10/15/2026.

Footnote F2

The reporting person owns 1,066,487 shares directly and/or indirectly as follows: (i) 168,170 shares of common stock owned by the reporting person, (ii) 150,930 shares in five trusts, each of which has been established for a separate grandchild of the Reporting Person, with each trust owning an aggregate of 30,186 shares of common stock, all trusts with the same terms, over which the Reporting Person has voting and dispositive authority, (iii) 747,387 shares of common stock owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of MFE, LLC and therefore disclaims 149,478 shares of the 747,387 shares of common stock owned by MFE, LLC, which 149,478 shares are beneficially owned by other members of the limited liability company.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .